Review



unconjugated anti batf rabbit mab  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc unconjugated anti batf rabbit mab
    Unconjugated Anti Batf Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+batf+rabbit+mab/pm41916318-314-0-5
    Average 86 stars, based on 1 article reviews
    unconjugated anti batf rabbit mab - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation.
    Article Snippet: Article Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation

    Affinity Purification:

    Article Title: Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation.
    Article Snippet: Article Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation

    Immunoprecipitation:

    Article Title: Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation.
    Article Snippet: Article Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation

    Control:

    Article Title: Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation.
    Article Snippet: Article Foxp3 and BATF cooperatively direct cis-regulatory programs and gene expression for effector Treg cell differentiation



    Similar Products

    86
    Cell Signaling Technology Inc unconjugated anti batf rabbit mab
    Unconjugated Anti Batf Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+batf+rabbit+mab/pm41916318-314-0-5
    Average 86 stars, based on 1 article reviews
    unconjugated anti batf rabbit mab - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti batf rabbit mab
    Anti Batf Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+batf+rabbit+mab/BATF+Rabbit+mAb/pm41916318-364-12-17
    Average 94 stars, based on 1 article reviews
    anti batf rabbit mab - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    98
    Cell Signaling Technology Inc batf
    Tumor <t>induced</t> <t>PD-L1</t> expression in neutrophils enhances IL31 secretion of CD8 + T cells. (A) IL31 and OSM mRNA level in CD8 + T cells after co-cultured neutrophils and GC cells. (B) TIM-3, PD-1 and IL31 mRNA level in CD8 + T cells treated with IL2 and Anti-CD3/CD28 antibody. (C) IL31 mRNA and protein level in CD8 + T cells co-cultured with neutrophils treated with BMP5 and PD-L1 inhibitor (Atezolizumab). (D) Schematic of PD-1/PD-L1 signaling pathway in CD8 + T cells. (E) <t>BATF</t> mRNA and protein level in CD8 + T cells treated with IL2 and Anti-CD3/CD28 antibody for 0 day and 14 days. (F) BATF mRNA and protein level in CD8 + T cells after co-cultured neutrophils and GC cells. (G) IL31 mRNA and protein level in CD8 + T cells when BATF was up-regulated or down-regulated. (H) Dual-Luciferase Reporter Assay analysis for BATF-binding IL31 promoter. (I) p-PI3K, PI3K, p-AKT, AKT, p-P27, P27, CCNE2, PD-L1, and PD-L2 expression in MKN28 cells treated with supernatant of CD8 + T cells (J) mIF staining analysis of correlation of OSMR, CD15, CD8, and IL31 in tumor samples from patients in Cohort 2. (**, P < 0.01).
    Batf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+batf+rabbit+mab/PD-L1+XP+Rabbit+mAb/pmc12906089-52-79-80
    Average 98 stars, based on 1 article reviews
    batf - by Bioz Stars, 2026-10
    98/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti batf
    Tumor <t>induced</t> <t>PD-L1</t> expression in neutrophils enhances IL31 secretion of CD8 + T cells. (A) IL31 and OSM mRNA level in CD8 + T cells after co-cultured neutrophils and GC cells. (B) TIM-3, PD-1 and IL31 mRNA level in CD8 + T cells treated with IL2 and Anti-CD3/CD28 antibody. (C) IL31 mRNA and protein level in CD8 + T cells co-cultured with neutrophils treated with BMP5 and PD-L1 inhibitor (Atezolizumab). (D) Schematic of PD-1/PD-L1 signaling pathway in CD8 + T cells. (E) <t>BATF</t> mRNA and protein level in CD8 + T cells treated with IL2 and Anti-CD3/CD28 antibody for 0 day and 14 days. (F) BATF mRNA and protein level in CD8 + T cells after co-cultured neutrophils and GC cells. (G) IL31 mRNA and protein level in CD8 + T cells when BATF was up-regulated or down-regulated. (H) Dual-Luciferase Reporter Assay analysis for BATF-binding IL31 promoter. (I) p-PI3K, PI3K, p-AKT, AKT, p-P27, P27, CCNE2, PD-L1, and PD-L2 expression in MKN28 cells treated with supernatant of CD8 + T cells (J) mIF staining analysis of correlation of OSMR, CD15, CD8, and IL31 in tumor samples from patients in Cohort 2. (**, P < 0.01).
    Anti Batf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+batf+rabbit+mab/BATF+Rabbit+mAb/pm41272167-295-65-68
    Average 94 stars, based on 1 article reviews
    anti batf - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti batf antibody
    A Fosl2 and HTLV-1 Tax enrichment (ChIP-seq) in HCT-4 cells and chromatin accessibility (ATAC-seq) in HTLV-1-infected CD4 + T cells in patients with HAM, highlighting the HAM-characteristic OCR. Genomic DNA from HCT-4 cells prior to immunoprecipitation served as input control. ChIP-seq and ATAC-seq peaks were visualized with IGV (data range: ChIP-seq, 0-30; ATAC-seq, 0-100). B Enrichment analysis of transcription factor motifs in ChIP-seq with Fosl2 using the HOMER algorithm. Motifs are ranked by -log10(P). Statistical analysis was performed using a one-sided hypergeometric test. Nominal P values are reported. C Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR at the MAP3K8 locus. Relative luciferase activity for Fosl2 with partner factors <t>(c-Jun,</t> <t>JunB,</t> <t>BATF,</t> and BATF3) was examined. Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s honestly significant difference (HSD) test for multiple comparisons. Asterisks indicate statistical significance (*** P < 0.001). n = 3, 4, or 5 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. D Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR, with Fosl2, c-Jun, and HTLV-1 Tax. Yellow arrows indicate OCR orientation (5’ → 3’ or 3’ → 5’). Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s HSD test for multiple comparisons. Exact P value are as follows: MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (5’ → 3’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000010, MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (3’ → 5’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000021. Asterisks indicate statistical significance (*** P < 0.001). n = 4 or 7 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. E Representative histograms depicting chromatin accessibility at the MAP3K8 locus, as determined by ATAC-seq analysis, across various CD4⁺ T cell populations: resting normal CD4⁺ T cells, HAM_D subset, CD4⁺ T cells transiently expressing HTLV-1 Tax for 7 days via a lentiviral system (Tax-cell), and CD4⁺ T cells activated with anti-CD3/CD28 antibodies ( GSM5554060 ). The highlighted region shows HAM-characteristic OCR. ATAC-seq peaks were visualized with IGV (data range: 0-100).
    Anti Batf Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+batf+rabbit+mab/BATF+Rabbit+mAb/pmc12603273-407-12-16
    Average 94 stars, based on 1 article reviews
    anti batf antibody - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc anti batf af647
    A Fosl2 and HTLV-1 Tax enrichment (ChIP-seq) in HCT-4 cells and chromatin accessibility (ATAC-seq) in HTLV-1-infected CD4 + T cells in patients with HAM, highlighting the HAM-characteristic OCR. Genomic DNA from HCT-4 cells prior to immunoprecipitation served as input control. ChIP-seq and ATAC-seq peaks were visualized with IGV (data range: ChIP-seq, 0-30; ATAC-seq, 0-100). B Enrichment analysis of transcription factor motifs in ChIP-seq with Fosl2 using the HOMER algorithm. Motifs are ranked by -log10(P). Statistical analysis was performed using a one-sided hypergeometric test. Nominal P values are reported. C Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR at the MAP3K8 locus. Relative luciferase activity for Fosl2 with partner factors <t>(c-Jun,</t> <t>JunB,</t> <t>BATF,</t> and BATF3) was examined. Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s honestly significant difference (HSD) test for multiple comparisons. Asterisks indicate statistical significance (*** P < 0.001). n = 3, 4, or 5 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. D Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR, with Fosl2, c-Jun, and HTLV-1 Tax. Yellow arrows indicate OCR orientation (5’ → 3’ or 3’ → 5’). Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s HSD test for multiple comparisons. Exact P value are as follows: MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (5’ → 3’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000010, MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (3’ → 5’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000021. Asterisks indicate statistical significance (*** P < 0.001). n = 4 or 7 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. E Representative histograms depicting chromatin accessibility at the MAP3K8 locus, as determined by ATAC-seq analysis, across various CD4⁺ T cell populations: resting normal CD4⁺ T cells, HAM_D subset, CD4⁺ T cells transiently expressing HTLV-1 Tax for 7 days via a lentiviral system (Tax-cell), and CD4⁺ T cells activated with anti-CD3/CD28 antibodies ( GSM5554060 ). The highlighted region shows HAM-characteristic OCR. ATAC-seq peaks were visualized with IGV (data range: 0-100).
    Anti Batf Af647, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+batf+rabbit+mab/BATF+Rabbit+mAb/pmc12488371-23-0-4
    Average 93 stars, based on 1 article reviews
    anti batf af647 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti batf pe
    A Fosl2 and HTLV-1 Tax enrichment (ChIP-seq) in HCT-4 cells and chromatin accessibility (ATAC-seq) in HTLV-1-infected CD4 + T cells in patients with HAM, highlighting the HAM-characteristic OCR. Genomic DNA from HCT-4 cells prior to immunoprecipitation served as input control. ChIP-seq and ATAC-seq peaks were visualized with IGV (data range: ChIP-seq, 0-30; ATAC-seq, 0-100). B Enrichment analysis of transcription factor motifs in ChIP-seq with Fosl2 using the HOMER algorithm. Motifs are ranked by -log10(P). Statistical analysis was performed using a one-sided hypergeometric test. Nominal P values are reported. C Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR at the MAP3K8 locus. Relative luciferase activity for Fosl2 with partner factors <t>(c-Jun,</t> <t>JunB,</t> <t>BATF,</t> and BATF3) was examined. Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s honestly significant difference (HSD) test for multiple comparisons. Asterisks indicate statistical significance (*** P < 0.001). n = 3, 4, or 5 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. D Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR, with Fosl2, c-Jun, and HTLV-1 Tax. Yellow arrows indicate OCR orientation (5’ → 3’ or 3’ → 5’). Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s HSD test for multiple comparisons. Exact P value are as follows: MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (5’ → 3’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000010, MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (3’ → 5’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000021. Asterisks indicate statistical significance (*** P < 0.001). n = 4 or 7 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. E Representative histograms depicting chromatin accessibility at the MAP3K8 locus, as determined by ATAC-seq analysis, across various CD4⁺ T cell populations: resting normal CD4⁺ T cells, HAM_D subset, CD4⁺ T cells transiently expressing HTLV-1 Tax for 7 days via a lentiviral system (Tax-cell), and CD4⁺ T cells activated with anti-CD3/CD28 antibodies ( GSM5554060 ). The highlighted region shows HAM-characteristic OCR. ATAC-seq peaks were visualized with IGV (data range: 0-100).
    Anti Batf Pe, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+batf+rabbit+mab/BATF+Rabbit+mAb/pmc12488371-24-0-4
    Average 94 stars, based on 1 article reviews
    anti batf pe - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    Tumor induced PD-L1 expression in neutrophils enhances IL31 secretion of CD8 + T cells. (A) IL31 and OSM mRNA level in CD8 + T cells after co-cultured neutrophils and GC cells. (B) TIM-3, PD-1 and IL31 mRNA level in CD8 + T cells treated with IL2 and Anti-CD3/CD28 antibody. (C) IL31 mRNA and protein level in CD8 + T cells co-cultured with neutrophils treated with BMP5 and PD-L1 inhibitor (Atezolizumab). (D) Schematic of PD-1/PD-L1 signaling pathway in CD8 + T cells. (E) BATF mRNA and protein level in CD8 + T cells treated with IL2 and Anti-CD3/CD28 antibody for 0 day and 14 days. (F) BATF mRNA and protein level in CD8 + T cells after co-cultured neutrophils and GC cells. (G) IL31 mRNA and protein level in CD8 + T cells when BATF was up-regulated or down-regulated. (H) Dual-Luciferase Reporter Assay analysis for BATF-binding IL31 promoter. (I) p-PI3K, PI3K, p-AKT, AKT, p-P27, P27, CCNE2, PD-L1, and PD-L2 expression in MKN28 cells treated with supernatant of CD8 + T cells (J) mIF staining analysis of correlation of OSMR, CD15, CD8, and IL31 in tumor samples from patients in Cohort 2. (**, P < 0.01).

    Journal: Neoplasia (New York, N.Y.)

    Article Title: OSMR coordinates a self-perpetuating circuit linking chemoresistance and neutrophil-driven immunosuppression in gastric cancer

    doi: 10.1016/j.neo.2026.101279

    Figure Lengend Snippet: Tumor induced PD-L1 expression in neutrophils enhances IL31 secretion of CD8 + T cells. (A) IL31 and OSM mRNA level in CD8 + T cells after co-cultured neutrophils and GC cells. (B) TIM-3, PD-1 and IL31 mRNA level in CD8 + T cells treated with IL2 and Anti-CD3/CD28 antibody. (C) IL31 mRNA and protein level in CD8 + T cells co-cultured with neutrophils treated with BMP5 and PD-L1 inhibitor (Atezolizumab). (D) Schematic of PD-1/PD-L1 signaling pathway in CD8 + T cells. (E) BATF mRNA and protein level in CD8 + T cells treated with IL2 and Anti-CD3/CD28 antibody for 0 day and 14 days. (F) BATF mRNA and protein level in CD8 + T cells after co-cultured neutrophils and GC cells. (G) IL31 mRNA and protein level in CD8 + T cells when BATF was up-regulated or down-regulated. (H) Dual-Luciferase Reporter Assay analysis for BATF-binding IL31 promoter. (I) p-PI3K, PI3K, p-AKT, AKT, p-P27, P27, CCNE2, PD-L1, and PD-L2 expression in MKN28 cells treated with supernatant of CD8 + T cells (J) mIF staining analysis of correlation of OSMR, CD15, CD8, and IL31 in tumor samples from patients in Cohort 2. (**, P < 0.01).

    Article Snippet: The membranes were blocked with 5% non-fat milk in TBST for 1 hour at room temperature, followed by an overnight incubation at 4°C with primary antibodies (OSMR (Abcam, #ab315388), CCNE2 (Abcam, #ab40890), β-actin (CST, #4967), PI3K (P85) (CST, #4292), p-PI3K (p-P85) (Abcam, #ab278545), AKT (CST, #9272), p-AKT (CST, #4060), P27 (CST, #2552), p-P27 (Abcam, #ab62364), FLAG (CST, #14793), BMP5 (Proteintech, #13253-1-AP), Ub (CST, #20326), TRIM2 (Proteintech, #20356-1-AP), GATA3 (CST, #5852), p-SMAD1/5 (CST, #9516), SMAD5 (CST, #12534), PD-L1 (CST, #13684), BATF (CST, #8638), IL-31 (abcam, #ab62579)), which were diluted in accordance with the manufacturer's instructions.

    Techniques: Expressing, Cell Culture, Luciferase, Reporter Assay, Binding Assay, Staining

    A Fosl2 and HTLV-1 Tax enrichment (ChIP-seq) in HCT-4 cells and chromatin accessibility (ATAC-seq) in HTLV-1-infected CD4 + T cells in patients with HAM, highlighting the HAM-characteristic OCR. Genomic DNA from HCT-4 cells prior to immunoprecipitation served as input control. ChIP-seq and ATAC-seq peaks were visualized with IGV (data range: ChIP-seq, 0-30; ATAC-seq, 0-100). B Enrichment analysis of transcription factor motifs in ChIP-seq with Fosl2 using the HOMER algorithm. Motifs are ranked by -log10(P). Statistical analysis was performed using a one-sided hypergeometric test. Nominal P values are reported. C Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR at the MAP3K8 locus. Relative luciferase activity for Fosl2 with partner factors (c-Jun, JunB, BATF, and BATF3) was examined. Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s honestly significant difference (HSD) test for multiple comparisons. Asterisks indicate statistical significance (*** P < 0.001). n = 3, 4, or 5 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. D Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR, with Fosl2, c-Jun, and HTLV-1 Tax. Yellow arrows indicate OCR orientation (5’ → 3’ or 3’ → 5’). Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s HSD test for multiple comparisons. Exact P value are as follows: MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (5’ → 3’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000010, MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (3’ → 5’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000021. Asterisks indicate statistical significance (*** P < 0.001). n = 4 or 7 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. E Representative histograms depicting chromatin accessibility at the MAP3K8 locus, as determined by ATAC-seq analysis, across various CD4⁺ T cell populations: resting normal CD4⁺ T cells, HAM_D subset, CD4⁺ T cells transiently expressing HTLV-1 Tax for 7 days via a lentiviral system (Tax-cell), and CD4⁺ T cells activated with anti-CD3/CD28 antibodies ( GSM5554060 ). The highlighted region shows HAM-characteristic OCR. ATAC-seq peaks were visualized with IGV (data range: 0-100).

    Journal: Nature Communications

    Article Title: Chromatin remodeling enhances MAP3K8 expression in HAM: a key pathogenesis for therapeutic intervention

    doi: 10.1038/s41467-025-64836-7

    Figure Lengend Snippet: A Fosl2 and HTLV-1 Tax enrichment (ChIP-seq) in HCT-4 cells and chromatin accessibility (ATAC-seq) in HTLV-1-infected CD4 + T cells in patients with HAM, highlighting the HAM-characteristic OCR. Genomic DNA from HCT-4 cells prior to immunoprecipitation served as input control. ChIP-seq and ATAC-seq peaks were visualized with IGV (data range: ChIP-seq, 0-30; ATAC-seq, 0-100). B Enrichment analysis of transcription factor motifs in ChIP-seq with Fosl2 using the HOMER algorithm. Motifs are ranked by -log10(P). Statistical analysis was performed using a one-sided hypergeometric test. Nominal P values are reported. C Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR at the MAP3K8 locus. Relative luciferase activity for Fosl2 with partner factors (c-Jun, JunB, BATF, and BATF3) was examined. Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s honestly significant difference (HSD) test for multiple comparisons. Asterisks indicate statistical significance (*** P < 0.001). n = 3, 4, or 5 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. D Enhancer assays using the MAP3K8 promoter and HAM-characteristic OCR, with Fosl2, c-Jun, and HTLV-1 Tax. Yellow arrows indicate OCR orientation (5’ → 3’ or 3’ → 5’). Data are presented as mean values + SD. Statistical significance was assessed by one-way ANOVA followed by two-sided Tukey’s HSD test for multiple comparisons. Exact P value are as follows: MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (5’ → 3’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000010, MAP3K8 promoter with Fosl2, c-Jun, and HTLV-1 Tax vs MAP3K8 promoter and HAM-characteristic OCR (3’ → 5’) with Fosl2, c-Jun, and HTLV-1 Tax, P = 0.000021. Asterisks indicate statistical significance (*** P < 0.001). n = 4 or 7 biologically independent experiments, each performed on separate days using independently transfected HEK293 cells. E Representative histograms depicting chromatin accessibility at the MAP3K8 locus, as determined by ATAC-seq analysis, across various CD4⁺ T cell populations: resting normal CD4⁺ T cells, HAM_D subset, CD4⁺ T cells transiently expressing HTLV-1 Tax for 7 days via a lentiviral system (Tax-cell), and CD4⁺ T cells activated with anti-CD3/CD28 antibodies ( GSM5554060 ). The highlighted region shows HAM-characteristic OCR. ATAC-seq peaks were visualized with IGV (data range: 0-100).

    Article Snippet: Anti-c-Jun antibody (9165S, Cell Signaling Technology) Anti-JunB antibody (sc-8051, Santa Cruz Biotechnology) Anti-BATF antibody (8638 T, Cell Signaling Technology) Anti-BATF3 antibody (GTX130125, Gene Tex) Anti-Tax antibody (LT-4, kindly gifted by Dr. Yuetsu Tanaka) Anti-Rabbit IgG (whole molecule)-Peroxidase antibody (A9169, Sigma-Aldrich) Anti-Mouse IgG (whoke molecule)-Peroxidase antibody (A5278, Sima-Aldrich) ECL Prime Western Blotting Detection Reagent (Cytiva, Little Chalfront, England)

    Techniques: ChIP-sequencing, Infection, Immunoprecipitation, Control, Luciferase, Activity Assay, Transfection, Expressing